Performance of the GlucoMen® Day (WaveForm Cascade) Continuous Glucose Monitor (CGM) in daily practice

Performance of the GlucoMen® Day (WaveForm Cascade) Continuous Glucose Monitor (CGM) in daily practice - Performance of the GlucoMen® Day Continuous Glucose Monitor

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49722

Enrollment

Registered

2020-08-13

Start date

2020-08-01

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects with type 1 diabetes mellitus, using insulin either by MDI or CSII. Ability to provide oral and written informed consent

Exclusion criteria

Exclusion criteria: Main exclusion criteria are the inability to understand the Dutch language and the presence of a severe or unstable medical condition.

Design outcomes

Primary

Measure	Time frame
The performance of the M-CGM compared to Nova capillary test strip during the 14-day study period.	—

Secondary

Measure	Time frame
The performance of the M-CGM compared to FGM and rt-CGM	—

Countries

Netherlands

Outcome results